ro7198457
Showing 1 - 2 of 2
NSCLC (NSCLC) Trial (Atezolizumab, RO7198457)
Withdrawn
- Non-small Cell Lung Cancer (NSCLC)
- Atezolizumab
- RO7198457
- (no location specified)
Feb 1, 2021
Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)
Active, not recruiting
- Pancreatic Cancer
- Atezolizumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 12, 2022